2070.SR Stock — Price, Charts & Analysis

Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR) has a trailing P/E of 17.52x and a forward P/E of 24.50x. This places 2070.SR in a moderate earnings multiple territory based on the valuation data currently available on Worldtickers.

2070.SR trades with 17.52x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether 2070.SR looks overvalued or undervalued.

2070.SR's P/E of 17.52x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

2070.SR's trailing EPS is SAR 1.79 and forward EPS is SAR 1.28. Reported earnings growth is 103.60%, which helps show current profit momentum.

EPS, or earnings per share, shows how much profit Saudi Pharmaceutical Industries and Medical Appliances Corporation generated for each share. 2070.SR's trailing EPS is SAR 1.79, and investors usually prefer EPS that is positive and growing over time.

Saudi Pharmaceutical Industries and Medical Appliances Corporation has a market cap of SAR 3.74B, making 2070.SR a mid-cap stock based on the current market value shown on Worldtickers.

2070.SR's latest stock price on Worldtickers is SAR 31.36. The latest move is SAR 0.06 or 0.19%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

2070.SR's quote includes a latest price of SAR 31.36. The market open is SAR 31.24. Previous close is SAR 31.30. The intraday range is SAR 31.10 to SAR 31.42.

2070.SR is up in the latest quote, with a move of SAR 0.06 or 0.19%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

2070.SR generated SAR 1.74B in trailing revenue. Revenue growth is 23.00%, which helps show whether demand is expanding or slowing.

2070.SR's revenue growth is 23.00%, which is a strong demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

Yes, 2070.SR shows positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is SAR 214.39M.

Gross margin is 50.29%. Margins show how efficiently Saudi Pharmaceutical Industries and Medical Appliances Corporation turns revenue into profit.

Saudi Pharmaceutical Industries and Medical Appliances Corporation carries SAR 1.45B and holds SAR 370.82M in cash.

2070.SR holds SAR 370.82M on its balance sheet.

2070.SR's book value per share is SAR 14.15.

Yes, Saudi Pharmaceutical Industries and Medical Appliances Corporation pays a dividend of SAR 0.35 per share annually. The dividend yield is 112.00%. The payout ratio is 19.55%.

2070.SR's dividend yield is 112.00%. Its payout ratio is 19.55%, which helps judge dividend sustainability. Dividend investors usually prefer a reasonable yield, consistent cash flow, and a payout ratio that leaves room for reinvestment.

Worldtickers does not currently show a confirmed next ex-dividend date for 2070.SR. The page does show dividend rate and yield when available, and investors should confirm record and payment dates through Saudi Pharmaceutical Industries and Medical Appliances Corporation's investor relations materials.

2070.SR's five-year average dividend yield is 300.00%. Use this alongside current yield, payout ratio, and cash flow to understand whether today's dividend looks high or low versus recent history.

Institutions hold 4.33% of 2070.SR shares. Insiders hold 10.49% of shares. Ownership mix helps investors understand how much of Saudi Pharmaceutical Industries and Medical Appliances Corporation is held by professional investors and company insiders.

2070.SR has 119.36M shares outstanding. Float shares are 86.49M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for 2070.SR, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for 2070.SR is SAR 1.28. Earnings growth is 103.60%. Revenue growth is 23.00%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

2070.SR's trailing EPS is SAR 1.79. Forward EPS is SAR 1.28. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

2070.SR is in the Healthcare sector. Its earnings multiple is 17.52x. Its latest displayed growth metric is 23.00%. Compare these figures with sector peers before deciding whether Saudi Pharmaceutical Industries and Medical Appliances Corporation is stronger or weaker than average.

2070.SR trades at SAR 31.36. The stock trades at 17.52x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Saudi Pharmaceutical Industries and Medical Appliances Corporation's fundamentals.

2070.SR risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 0.43, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

2070.SR should be compared with companies in Drug Manufacturers - Specialty & Generic. Its earnings multiple is 17.52x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR) operates in Healthcare, specifically Drug Manufacturers - Specialty & Generic. Saudi Pharmaceutical Industries and Medical Appliances Corporation develops, manufactures, and markets medicinal and pharmaceutical products in the Kingdom of Saudi Arabia, the Middle East, Egypt, Algeria, and Morocco. The company operates through Pharmaceutical Manufacturing, Trading and Distribution Services, and Healthcare Services segments. The company is involved in the sale, marketing, and distribution of pharmaceutical, veterinary, medical equipment, and cosmetics products; and operates and maintains a secon

2070.SR trades on Saudi. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

2070.SR stock is priced in SAR on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Saudi Pharmaceutical Industries and Medical Appliances Corporation's official website listed on Worldtickers is www.spimaco.com.sa. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Saudi Pharmaceutical Industries and Medical Appliances Corporation is headquartered in Buraydah, Saudi Arabia. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

2070.SR is in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

2070.SR has traded between SAR 24.96 and SAR 33.12 over the past 52 weeks. At SAR 31.36, it is 5.31% below the high and 25.64% above the low. The 52-week range helps gauge long-term price momentum.

2070.SR is above both its 50-day and 200-day moving averages, which is a common uptrend signal. Its 50-day moving average is SAR 29.99 and its 200-day moving average is SAR 28.82.

2070.SR's RSI is 58.18. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

2070.SR's latest RSI reading is 58.18, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for 2070.SR is near SAR 29.86. Key resistance is near SAR 32.00. Breaks above resistance or below support can change the short-term technical setup.

2070.SR's nearest reported support level is SAR 29.86. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

2070.SR's nearest reported resistance level is SAR 32.00. A breakout above resistance can improve momentum, especially when volume confirms the move.

2070.SR trades about 778.08K shares daily on average. The latest displayed volume is 160.02K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

2070.SR's MACD is -0.06, which is a negative momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

2070.SR is above both its 50-day and 200-day moving averages, which is a common uptrend signal. RSI is 58.18 (neutral). MACD is bearish. Nearest support is around SAR 29.86. Resistance is around SAR 32.00. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is SAR 31.06 (0.97% from price). MA50 is SAR 29.99 (4.55% from price). MA200 is SAR 28.82 (8.82% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. 2070.SR's MA20 is SAR 31.06. MA50 is SAR 29.99. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

2070.SR's pivot is near SAR 31.15. Support is near SAR 29.86. Resistance is near SAR 32.00. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for 2070.SR is near SAR 30.74. The next upper resistance zone is near SAR 32.20. These levels help define risk and possible follow-through zones after a breakout or breakdown.

2070.SR's Bollinger range is roughly SAR 30.19 to SAR 31.93. Band width is near 5.59%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

2070.SR's ATR-based typical daily range is about 1.74%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 160.02K shares. Average volume is about 778.08K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

2070.SR's all-time high shown on Worldtickers is SAR 61.40. Its all-time low is SAR 17.98. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

2070.SR has a beta of 0.43, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.